Efficacy and Safety of Auto-FMT in Preventing aGVHD
Recruiting
N/A
Interventional Study
Graft Versus Host Disease, Acute
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 100 (estimated)
- Sponsor
- The First Affiliated Hospital of Soochow University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To evaluation the efficacy and safety of autologous fecal bacteria transplantation in preventing acute graft versus host disease after haploidentical hematopoietic stem cell transplantation. Bone marrow transplant patients were recruited.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Haplo-HSCT patients; Bacteroidetes \>0.1%; inverse Simpson diversity ≥2
Exclusion Criteria:
* Gastrointestinal diseases；Age\>60; or Age\<10；Probiotics or prebiotics were taken before enrollment
Contacts
No contact information available.